Segantii Capital Management’s Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00 CLDI.WS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-25,000
| Closed | -$262K | – | 196 |
|
|
2023
Q2 | $262K | Hold |
25,000
| – | – | 0.01% | 142 |
|
|
2023
Q1 | $257K | Hold |
25,000
| – | – | 0.01% | 251 |
|
|
2022
Q4 | $254K | Hold |
25,000
| – | – | 0.01% | 337 |
|
|
2022
Q3 | $246K | Hold |
25,000
| – | – | 0.01% | 460 |
|
|
2022
Q2 | $249 | Hold |
25,000
| – | – | 0.01% | 439 |
|
|
2022
Q1 | $247K | Hold |
25,000
| – | – | 0.01% | 464 |
|
|
2021
Q4 | $245K | Buy |
+25,000
| New | +$245K | 0.01% | 440 |
|